Clinicopathologic studies in cognitively healthy aging and Alzheimer disease: Relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype

Archives of Neurology

Volumn 55, Issue 3, 1998, Pages 326-335

  Berg, Leonard ^a   McKeel Jr , Daniel W ^a   Miller, J Philip ^a   Storandt, Martha ^a   Rubin, Eugene H ^a   Morris, John C ^a   Baty, Jack ^a   Coats, Mary ^a   Norton, Joanne ^a   Goate, Alison M ^a   Price, Joseph L ^a   Gearing, Maria ^b   Mirra, Susanne S ^b   Saunders, Ann M ^c  

^a WASHINGTON UNIVERSITY   (United States)

^b EMORY UNIVERSITY   (United States)

^c DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; AGING; ALLELE; ALZHEIMER DISEASE; ARTICLE; COGNITION; DEGENERATIVE DISEASE; FEMALE; GENE FREQUENCY; HISTOPATHOLOGY; HUMAN; LEWY BODY; MAJOR CLINICAL STUDY; MALE; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; SENILE PLAQUE;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BRAIN; COGNITION; FEMALE; GENOTYPE; HUMANS; LONGITUDINAL STUDIES; MALE; NEUROFIBRILLARY TANGLES; ORGAN SIZE; PROSPECTIVE STUDIES; SENILE PLAQUES;

EID: 14444285507     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.55.3.326     Document Type: Article

References (97)

1. Berg L, McKeel DW Jr, Miller JP, Baty J, Morris JC. Neuropathologic indexes of Alzheimer's disease in demented and nondemented people aged 80 years and older. Arch Neurol. 1993;50:349-358.
2. Mann DMA, Yates PO, Marcyniuk B. Some morphometric observations on the cerebral cortex and hippocampus in presenile Alzheimer's disease, senile dementia of the Alzheimer type and Down's syndrome in middle age. J Neurol Sci. 1985;69:139-159.
3. Bondareff W, Mountjoy CQ, Roth M, Rossor MN, Iverson LL, Reynolds GP. Age and histopathological heterogeneity in Alzheimer's disease: evidence for subtypes. Arch Gen Psychiatry. 1987;44:412-417.
4. Coleman PD, Flood DG. Neuron numbers and dendritic extent in normal aging and Alzheimer's disease. Neurobiol Aging. 1987;8:521-545.
5. Hansen LA, DeTeresa R, Terry RD. Neocortical morphometry, lesion counts, and choline acetyltransferase levels in the age spectrum of Alzheimer's disease. Neurology. 1988;38:48-54.
6. Katzman R, Terry RD, DeTeresa R, et al. Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol. 1988;23:53-59.
7. Crystal H, Dickson DW, Fuld P, et al. Clinicopathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology. 1988;38:1682-1687.
8. Dickson DW, Crystal HA, Mattiace LA, et al. Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging. 1992;13:179-189.
9. Morris JC, McKeel DW Jr, Storandt M, et al. Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathological distinction from normal aging. Neurology. 1991;41:469-478.
10. Morris JC, Storandt M, McKeel DW Jr, et al. Cerebral amyloid deposition and diffuse plaques in "normal" aging: evidence for presymptomatic and very mild Alzheimer's disease. Neurology. 1996;46:707-719.
11. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993;43:1467-1472.
12. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high avidity binding to b-amyloid and increased frequency of type 4 allele in late onset familial Alzheimer disease. Proc Natl Acad Sci U S A. 1993;90:1977-1981.
13. Schmechel DE, Saunders AM, Strittmatter WJ, et al. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci U S A. 1993;90:9649-9653.
14. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron. 1993;11:575-580.
15. Roses AD. Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annu Rev Med. 1996;47:387-400.
16. Olichney JM, Hansen LA, Galasko D, et al. The apolipoprotein E ε4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology. 1996;47:190-196.
17. Hansen LA, Masliah E, Galasko D, Terry RD. Plaque-only Alzheimer's disease is usually the Lewy body variant, and vice versa. J Neuropathol Exp Neurol. 1993;52:648-654.
18. Berg L, Hughes CP, Coben LA, et al. Mild senile dementia of Alzheimer type: Research Diagnostic Criteria, recruitment, and description of a study population. J Neurol Neurosurg Psychiatry. 1982;45:962-968.
19. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan AM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS/ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
20. Roberts GW, Gentleman SM, Lynch A, Murray L, Landon M, Graham DI. β-Amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1994;57:419-425.
21. Adle-Biassette H, Duyckaerts C, Wasowicz M, et al. βAP deposition and head trauma. Neurobiol Aging. 1996;17:415-419.
22. Morris JC, McKeel DW Jr, Fulling K, Torack RM, Berg L. Validation of clinical diagnostic criteria for Alzheimer's disease. Ann Neurol. 1988;24:17-22.
23. Hughes CP, Berg L, Danziger WL, et al. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566-572.
24. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43:2412-2414.
25. Berg L, Miller JP, Storandt M, et al. Mild senile dementia of the Alzheimer type, 2: longitudinal assessment. Ann Neurol. 1988;23:477-484.
26. Burke WJ, Miller JP, Rubin EH, et al. Reliability of the Washington University Clinical Dementia Rating (CDR). Arch Neurol. 1988;45:31-32.
27. McCulla MM, Coats M, Van Fleet N, Duchek J, Grant E, Morris JC. Reliability of nurse specialists in the staging of dementia. Arch Neurol. 1989;46:1210-1211.
28. Davis PB, White H, Price JL, McKeel DW, Robins LN. Retrospective postmortem dementia assessment: validation of a new clinical interview to assist neuropathologic study. Arch Neurol. 1991;48:613-617.
29. American Psychiatric Association, Committee on Nomenclature and Statistics. Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition. Washington, DC: American Psychiatric Association; 1987.
30. Price JL, Davis PB, Morris JC, White DL. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol Aging. 1991;12:295-312.
31. Price JL. Tangles and plaques in healthy aging and Alzheimer's disease: independence or interaction? Semin Neurosci. 1994;6:395-402.
32. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha 1. J Lipid Res. 1990;31:545-548.
33. Talbot C, Houlden H, Craddock N, et al. Polymorphism in AACT gene may lower age of onset of Alzheimer's disease. Neuroreport. 1996;7:534-536.
34. Gearing M, Schneider JA, Rebeck GW, Hyman BT, Mirra SS. Alzheimer's disease with and without coexisting Parkinson's disease changes: apolipoprotein E genotype and neuropathologic correlates. Neurology. 1995;45:1985-1990.
35. De Souza AT, Hankins GR, Washington MK, Fine RL, Orton TC, Jirtle RL. Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors. Oncogene. 1995;10:1725-1729.
36. Hedreen JC, Raskin LS, Struble RG, Price DL. Selective silver impregnation of senile plaques: a method useful for computer imaging. J Neurosci Methods. 1988;25:151-158.
37. Hibbard LS, McKeel DW Jr. Automated identification and quantitative morphometry of the senile plaques of Alzheimer's disease. Analyt Quant Cytol Histol. 1997;19:123-138.
38. Khacnaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol. 1985;42:1097-1105.
39. Rezaie P, Cairns NJ, Chadwick A, Lantos PL. Lewy bodies are located preferentially in limbic areas in diffuse Lewy body disease. Neurosci Lett. 1996;212:111-114.
40. SAS/STAT Software: Changes and Enhancements Through Release 6.12. Cary, NC: SAS Institute Inc; 1997.
41. Kramer CY. Extension of the multiple range tests to group means with unequal numbers of replications. Biometrics. 1956;12:309-310.
42. Schmidt ML, DiDario AG, Lee VM-Y, Trojanowski JQ. An extensive network of PHF tau-rich dystrophic neuntes permeates neocortex and nearly all neuritic and diffuse amyloid plaques in Alzheimer disease. FEBS Lett. 1994;344:69-73.
43. McKee AC, Kosik KS, Kowall NW. Neuritic pathology and dementia in Alzheimer's disease. Ann Neurol. 1991;30:156-165.
44. Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease, Neurology. 1992;42:631-639.
45. Hyman BT, Marzloff K, Arriagada PV. The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution. J Neuropathol Exp Neurol. 1993;52:594-600.
46. Samuel W, Terry RD, DeTeresa R, Butters N, Masliah E. Clinical correlates of cortical and nucleus basalis pathology in Alzheimer dementia. Arch Neurol. 1994;51:772-778.
47. Dickson DW, Crystal HA, Bevona C, Honer W, Vincent I, Davies P. Correlations of synaptic and pathological markers with cognition of the elderly. Neurobiol Aging. 1995;16:285-297.
48. Dournaud P, DeLaére P, Hauw JJ, Epelbaum J. Differential correlation between neurochemical deficits, neuropathology, and cognitive status in Alzheimer's disease. Neurobiol Aging. 1995;16:817-823.
49. Bierer LM, Hof PR, Dushyant PP, et al. Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. Arch Neurol. 1995;52:81-88.
50. Gómez-Isla T, West HL, Rebeck GW, et al. Clinical and pathological correlates of apolipoprotein E ε4 in Alzheimer's disease. Ann Neurol. 1996;39:62-70.
51. Gómez-Isla T, Hollister R, West H, et al. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol. 1997;41:17-24.
52. Cummings BJ, Pike CJ, Shankle R, Cotman CW. β-Amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease. Neurobiol Aging. 1996;17:921-933.
53. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile changes in the cerebral grey matter of elderly subjects. Br J Psychiatry. 1968;114:797-811.
54. Terry RD. The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis. J Neuropathol Exp Neurol. 1996;55:1023-1025.
55. Terry RD, Masliah E, Salmon DP, et al. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991;30:572-580.
56. Gómez-Isla T, Price JL, McKeel DW, et al. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci. 1996;16:4491-4500.
57. Premkumar DRD, Cohen DL, Hedera P, Friedland RP, Kalaria RN. Apolipoprotein E-ε4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol. 1996;48:2083-2095.
58. Nagy Z, Esiri MM, Jobst KA, et al. The effects of additional pathology on the cognitive deficit in Alzheimer disease. J Neuropathol Exp Neurol. 1997;56:165-170.
59. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease: the Nun Study. JAMA. 1997;277:813-817.
60. Berg L, Miller JP, Baty J, Rubin EH, Morris JC, Figiel G. Mild senile dementia of the Alzheimer type. 4: evaluation of intervention. Ann Neurol. 1992;31:242-249.
61. Hill RD, Storandt M, LaBarge E. Psychometric discrimination of moderate senile dementia of the Alzheimer type. Arch Neurol. 1992;49:377-380.
62. Storandt M, Hill RD. Very mild senile dementia of the Alzheimer type, II: psychometric test performance. Arch Neurol. 1989;46:383-386.
63. Terry RD, Hansen LA, DeTeresa R, Davies P, Tobias H. Katzman R. Senile dementia of the Alzheimer type without neocortical neurofibrillary tangles. J Neuropathol Exp Neurol. 1987;46:262-268.
64. Hansen LA, Samuel W. Criteria for Alzheimer's disease and the nosology of dementia with Lewy bodies. Neurology. 1997;48:126-132.
65. Hulette C, Mirra SS, Wilkinson W, Heyman A, Fillenbaum G. Clark CM. CERAD part IX: a prospective cliniconeuropathologic study of Parkinson's features in Alzheimer's disease. Neurology. 1995;45:1991-1995.
66. Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet. 1994;7:180-184.
67. Rebeck GW, Perls TT, West HL, Sodhi P, Lipsitz LA, Hyman BT. Reduced apolipoprotein ε4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals [published correction appears in Neurology. 1995;45:598]. Neurology. 1994;44:1513-1516.
68. Corder EH, Saunders AM, Strittmatter WJ, et al. Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology. 1995;45:1323-1328.
69. Sobel E, Louhija J, Sulkava R, et al. Lack of association of apolipoprotein E allele ε4 with late-onset Alzheimer's disease among Finnish centenarians. Neurology. 1995;45:903-907.
70. Morris CM, Benjamin R, Leake A, et al. Effect of apolipoprotein E genotype on Alzheimer's disease neuropathology in a cohort of elderly Norwegians. Neurosci Lett. 1995;201:45-47.
71. Sulkava R, Kainulainen K, Verkkoniemi A, et al. APOE alleles in Alzheimer's disease and vascular dementia in a population aged 85+. Neurobiol Aging. 1996;17:373-376.
72. Blacker D, Haines JL, Rodes L, et al. ApoE-4 and age at onset of Alzheimer's disease: the NIMH Genetics Initiative. Neurology. 1997;48:139-147.
73. Polvikoski T, Sulkava R, Haltia M, et al. Apolipoprotein E, dementia, and cortical deposition of β-amyloid protein. N Engl J Med. 1995;333:1242-1247.
74. Gearing M, Mori H, Mirra SS. Aβ-peptide length and apolipoprotein E genotype in Alzheimer's disease. Ann Neurol. 1996;39:395-399.
75. Fabian VA, Jones TM, Wilton SD, et al. Alzheimer's disease and apolioprotein E genotype in western Australia: an autopsy-verified series. Med J Aust. 1996;165:77-80.
76. Landén M, Throsell A, Wallin A, Blennow K. The apolipoprotein E allele ε4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1996;61:352-356.
77. Pirttilä T, Soininen H, Mehta PD, et al. Apolipoprotein E genotype and amyloid load in Alzheimer disease and control brains. Neurobiol Aging. 1997;18:121-127.
78. Heinonen O, Lehtovirta M, Soininen H, et al. Alzheimer pathology of patients carrying apolipoprotein E ε4 allele. Neurobiol Aging. 1995;16:505-513.
79. Greenberg SM, Rebeck GW, Vonsattel JP, Gomez-Isla T, Hyman BT. Apolipoprotein E ε4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol. 1995;38:254-259.
80. Talbot CE, Lendon C, Craddock N, Shears S, Morris JC, Goale A. Protection against Alzheimer's disease with apoE ε2. Lancet. 1994;343:1432-1433.
81. Chartier-Harlin MC, Parfitt M, Legrain S, et al. Apolipoprotein E ε4 allele as a major risk factor for sporadic early and late-onset form of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet. 1994;3:569-574.
82. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part II: standardization of the neuropathological assessment of Alzheimer's disease. Neurology. 1991;41:479-486.
83. Katzman R, Terry RD. The Neurology of Aging. Philadelphia, Pa: FA Davis Co; 1983:40.
84. Ebly EM, Hogan DB, Parhad IM. Cognitive impairment in the nondemented elderly. Arch Neurol. 1995;52:612-619.
85. The National Institute on Aging and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging. 1997;18(4S):S1-S105.
86. Price JL. Diagnostic criteria for Alzheimer's disease: position paper. Neurobiol Aging. 1997;18(4S):S67-S70.
87. Berg L, Morris JC. Diagnosis. In: Terry RD, Katzman R, Bick K, eds. Alzheimer Disease. New York, NY: Raven Press; 1994:9-25.
88. Gearing M, Mirra SS, Sumi M, Hansen L, Hedreen J, Heyman A. CERAD part X: neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology. 1995;45:461-466.
89. Rasmusson DX, Brandt J, Steele C, Hedreen JC, Troncoso JC, Folstein MF. Accuracy of clinical diagnosis of Alzheimer disease and clinical features of patients with non-Alzheimer disease neuropathology. Alzheimer Dis Assoc Disord. 1996;10:180-188.
90. Torack RM, Morris JC. Mesolimbocorticaldementia. Arch Neurol. 1986;43:1074-1078.
91. Crystal HA, Dickson DW, Sliwinski MJ, et al. Pathological markers associated with normal aging and dementia in the elderly. Ann Neurol. 1993;34:566-573.
92. Dickson DW, Davies P, Bevona C, et al. Hippocampal sclerosis: a common pathological feature in very old (≥80 years of age) humans. Acta Neuropathol. 1994;88:212-221.
93. Corey-Bloom J, Sabbagh MN, Bondi MW, et al. Hippocampal sclerosis contributes to dementia in the elderly. Neurology. 1997;48:154-160.
94. Troncoso JC, Martin LJ, Dal Forno G, Kawas CH. Neuropathology in controls and demented subjects from the Baltimore Longitudinal Study of Aging. Neurobiol Aging. 1996;17:365-371.
95. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. Neurology. 1996;47:1113-1124.
96. Litvan I, Agid Y, Goetz C, et al. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology. 1997;48:119-125.
97. Bancher C, Jellinger KA. Neurofibrillary tangle predominant form of senile dementia of Alzheimer type: a rare subtype in very old subjects. Acta Neuropathol. 1994;88:567-570.